RightFit Trial Directory

Prostate Cancer clinical trials in Cleveland, OH

32 recruiting prostate cancer studies with a site in Cleveland, OH.

All trials in Cleveland, OH · All Prostate Cancer trials

RecruitingPhase 3NCT06136650

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Sponsor: Merck Sharp & Dohme LLC

Cleveland, OH · Gahanna, OH · Zanesville, OH · +60 more sites

RecruitingPhase 3NCT07611110

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Sponsor: AstraZeneca

Cleveland, OH · Dayton, OH · +25 more sites

RecruitingPhase 1NCT06465069

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Sponsor: Eli Lilly and Company

Cleveland, OH · +22 more sites

RecruitingPhase 1NCT06879041

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: AstraZeneca

Cleveland, OH · +11 more sites

RecruitingPhase 3NCT07028853

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Sponsor: Pfizer

Avon, OH · Cincinnati, OH · Cleveland, OH · +124 more sites

RecruitingNot applicableNCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Sponsor: Axonics, Inc.

Cleveland, OH · +22 more sites

RecruitingPhase 1 / Phase 2NCT07206056

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Sponsor: Novartis Pharmaceuticals

Cleveland, OH · +7 more sites

RecruitingPhase 3NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Sponsor: SWOG Cancer Research Network

Canton, OH · Centerville, OH · Cincinnati, OH · +331 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Cleveland, OH · +29 more sites

RecruitingNot applicableNCT06995898

The Vanguard Study: Testing a New Way to Screen for Cancer

Sponsor: National Cancer Institute (NCI)

Cleveland, OH · +44 more sites

RecruitingPhase 1 / Phase 2NCT04585750

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Sponsor: PMV Pharmaceuticals, Inc

Cleveland, OH · +31 more sites

RecruitingPhase 2NCT06632977

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Sponsor: Alliance for Clinical Trials in Oncology

Cleveland, OH · Columbus, OH · +106 more sites

RecruitingPhase 2NCT06738303

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Sponsor: Case Comprehensive Cancer Center

Cleveland, OH

RecruitingPhase 3NCT07200830

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Sponsor: Alliance for Clinical Trials in Oncology

Cleveland, OH · +137 more sites

RecruitingPhase 1NCT05176483

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Sponsor: Exelixis

Cleveland, OH · +45 more sites

RecruitingNot applicableNCT06496256

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

Sponsor: Palette Life Sciences, Inc.

Cleveland, OH · +10 more sites

RecruitingPhase 1NCT07082920

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Cleveland, OH · +3 more sites

RecruitingPhase 3NCT07164443

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Sponsor: Janssen Research & Development, LLC

Cincinnati, OH · Cleveland, OH · +52 more sites

RecruitingPhase 1NCT07319871

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Cleveland, OH · +2 more sites

RecruitingNot applicableNCT05868668

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

Sponsor: The Cleveland Clinic

Cleveland, OH

RecruitingPhase 1NCT06966024

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Sponsor: Deciphera Pharmaceuticals, LLC

Cleveland, OH · +7 more sites

RecruitingPhase 2NCT06842498

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Sponsor: Kyntra Bio

Cleveland, OH · +22 more sites

RecruitingNot applicableNCT05610852

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Sponsor: Case Comprehensive Cancer Center

Cleveland, OH

RecruitingPhase 3NCT06520345

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited

Cleveland, OH · +8 more sites

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Akron, OH · Avon, OH · Beachwood, OH · +371 more sites

RecruitingPhase not listedNCT07406282

A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Sponsor: Bayer

Cleveland, OH

RecruitingPhase not listedNCT03151629

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Sponsor: Prostate Cancer Clinical Trials Consortium

Cleveland, OH · +47 more sites

RecruitingPhase 2 / Phase 3NCT04787744

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Sponsor: VA Office of Research and Development

Cleveland, OH · +19 more sites

RecruitingNot applicableNCT05469269

Cleveland African American Prostate Cancer Project

Sponsor: Case Comprehensive Cancer Center

Cleveland, OH

RecruitingNot applicableNCT05590624

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

Sponsor: Case Comprehensive Cancer Center

Cleveland, OH

Not yet recruitingPhase 2NCT07608718

Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Sponsor: Pedro Barata, MD, MSc

Cleveland, OH

Not yet recruitingNot applicableNCT07040501

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Sponsor: Case Comprehensive Cancer Center

Cleveland, OH

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.